The University of Texas Southwestern Medical Center received a $164,000 Project Grant award from the Defense Health Agency on December 15, 2022 to fund research titled "Overcoming Jumonji KDM4A Oncogenic Function in SCLC" through December 14, 2023.
The grant supports the Military Medical Research and Development program of the Defense Health Agency, which aims to transform military and public health through innovative medical research solutions. Specifically, the grant will fund the University's research investigating potential medical solutions for small cell lung cancer (SCLC) by exploring the oncogenic function of the Jumonji KDM4A protein and ways to overcome it. As the prime awardee, the University will leverage its expertise in biomedical research to advance understanding of SCLC pathogenesis and identify potential therapeutic targets, contributing to the Defense Health Agency's goals of improving care for service members and the general public.
Generated 1/7/24, 10:32 AM